Ecp

DRUG2 trials

Sponsors

Mallinckrodt, University of Freiburg

Conditions

Acute Graft-versus-Host DiseaseColitisDermatitisHepatitisImmune Related Adverse Events

Phase 3

Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft Versus-Host Disease

TerminatedNCT00282503

MallinckrodtAcute Graft-versus-Host Disease

Start: 2006-01-31Updated: 2017-08-16

Unknown Phase

ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment

CompletedNCT05414552

University of FreiburgColitis, Dermatitis, Hepatitis +1

Start: 2021-06-01End: 2022-12-30Updated: 2023-08-01